SS Innovations publishes investor presentation on affordable, multi-specialty surgical robotics platform SSi Mantra 3

SS Innovations International, Inc

SS Innovations International, Inc

SSII

0.00

  • SS Innovations International investor deck highlights SSi Mantra 3 surgical robot platform, including instruments, AI/XR imaging-training tools, teleproctoring, and telesurgery capabilities.
  • Installed base spans 12 countries with 210 systems across 186 hospitals; 11,270 multi-specialty surgeries completed, including 587 robotic cardiac cases.
  • 171 telesurgeries completed; platform positioned for remote surgery access, with approvals cited for India, Indonesia, and the Philippines.
  • Regulatory roadmap targets EU CE in Q4 2026; US FDA in Q4 2026 or Q1 2027.
  • Company metrics cite 200,100,000 shares outstanding, recent price USD 3.36, market cap USD 0.7 billion, insider ownership about 72%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SS Innovations International Inc. published the original content used to generate this news brief on June 15, 2026, and is solely responsible for the information contained therein.